GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Small Ligand GPCRs

pathways : Small Ligand GPCRs pathways:

Fullview (zoomIn)


Related Genes to "Small Ligand GPCRs" content :

preload


Related products :

Catalog number Product name Quantity
E0096m ELISA kit C-C motif chemokine 19,Ccl19,EBI1 ligand chemokine,ELC,Elc,Epstein-Barr virus-induced molecule 1 ligand chemokine,Mouse,Mus musculus,Scya19,Small-inducible cytokine A19 96T
U0096m CLIA C-C motif chemokine 19,Ccl19,EBI1 ligand chemokine,ELC,Elc,Epstein-Barr virus-induced molecule 1 ligand chemokine,Mouse,Mus musculus,Scya19,Small-inducible cytokine A19 96T
E0096m ELISA C-C motif chemokine 19,Ccl19,EBI1 ligand chemokine,ELC,Elc,Epstein-Barr virus-induced molecule 1 ligand chemokine,Mouse,Mus musculus,Scya19,Small-inducible cytokine A19 96T
92354 Mix-n-Stain CF640R Small Ligand Labeling Kit 1 KIT
92350 Mix-n-Stain CF488A Small Ligand Labeling Kit 1 KIT
92351 Mix-n-Stain CF568 Small Ligand Labeling Kit 1 KIT
92362 Mix-n-Stain CF405M Small Ligand Labeling Kit 1 KIT
92359 Mix-n-Stain CF647 Small Ligand Labeling Kit 1 KIT
92360 Mix-n-Stain CF660C Small Ligand Labeling Kit 1 KIT
92361 Mix-n-Stain CF680 Small Ligand Labeling Kit 1 KIT
92353 Mix-n-Stain CF633 Small Ligand Labeling Kit 1 KIT
92355 Mix-n-Stain CF680R Small Ligand Labeling Kit 1 KIT
92352 Mix-n-Stain CF594 Small Ligand Labeling Kit 1 KIT
92357 Mix-n-Stain CF500 Small Ligand Labeling Kit 1 KIT
92358 Mix-n-Stain CF540 Small Ligand Labeling Kit 1 KIT
92356 Mix-n-Stain CF408 Small Ligand Labeling Kit 1 KIT
E0031h ELISA Apoptosis antigen ligand,APT1LG1,APTL,CD95 ligand,CD95L,CD95-L,Fas antigen ligand,Fas ligand,FASL,FASLG,Homo sapiens,Human,TNFSF6,Tumor necrosis factor ligand superfamily member 6 96T
E0031h ELISA kit Apoptosis antigen ligand,APT1LG1,APTL,CD95 ligand,CD95L,CD95-L,Fas antigen ligand,Fas ligand,FASL,FASLG,Homo sapiens,Human,TNFSF6,Tumor necrosis factor ligand superfamily member 6 96T
U0031h CLIA Apoptosis antigen ligand,APT1LG1,APTL,CD95 ligand,CD95L,CD95-L,Fas antigen ligand,Fas ligand,FASL,FASLG,Homo sapiens,Human,TNFSF6,Tumor necrosis factor ligand superfamily member 6 96T
U0031p CLIA CD95 ligand,CD95L,CD95-L,Fas antigen ligand,Fas ligand,FASL,FASLG,Pig,Sus scrofa,TNFSF6,Tumor necrosis factor ligand superfamily member 6 96T
E0031p ELISA CD95 ligand,CD95L,CD95-L,Fas antigen ligand,Fas ligand,FASL,FASLG,Pig,Sus scrofa,TNFSF6,Tumor necrosis factor ligand superfamily member 6 96T
E0031p ELISA kit CD95 ligand,CD95L,CD95-L,Fas antigen ligand,Fas ligand,FASL,FASLG,Pig,Sus scrofa,TNFSF6,Tumor necrosis factor ligand superfamily member 6 96T
E0031m ELISA kit Apt1lg1,CD95 ligand,Cd95l,CD95-L,Fas antigen ligand,Fas ligand,Fasl,Faslg,gld,Mouse,Mus musculus,Tnfsf6,Tumor necrosis factor ligand superfamily member 6 96T
U0031m CLIA Apt1lg1,CD95 ligand,Cd95l,CD95-L,Fas antigen ligand,Fas ligand,Fasl,Faslg,gld,Mouse,Mus musculus,Tnfsf6,Tumor necrosis factor ligand superfamily member 6 96T
E0031r ELISA kit Apt1Lg1,CD95 ligand,Cd95l,CD95-L,Fas antigen ligand,Fas ligand,Fasl,Faslg,Rat,Rattus norvegicus,Tnfsf6,Tumor necrosis factor ligand superfamily member 6 96T

Pathways :

WP247: Small Ligand GPCRs
WP971: Small Ligand GPCRs
WP746: Small Ligand GPCRs
WP1089: Small Ligand GPCRs
WP161: Small Ligand GPCRs
WP1317: Small Ligand GPCRs
WP853: Small Ligand GPCRs
WP353: Small Ligand GPCRs
WP1001: Peptide GPCRs
WP1338: Peptide GPCRs
WP1389: Monoamine GPCRs
WP80: Nucleotide GPCRs
WP1051: GPCRs, Class C Metabotropic glutamate, pheromone
WP334: GPCRs, Class B Secretin-like
WP409: GPCRs, Other
WP836: GPCRs, Class A Rhodopsin-like
WP1825: GPCR ligand binding
WP872: GPCRs, Other
WP1158: Nucleotide GPCRs
WP455: GPCRs, Class A Rhodopsin-like
WP1188: GPCRs, Class A Rhodopsin-like
WP501: GPCRs, Class C Metabotropic glutamate, pheromone
WP207: Nucleotide GPCRs
WP922: Nucleotide GPCRs
WP24: Peptide GPCRs

Related Genes :
[CCL19 ELC MIP3B SCYA19] C-C motif chemokine 19 (Beta-chemokine exodus-3) (CK beta-11) (Epstein-Barr virus-induced molecule 1 ligand chemokine) (EBI1 ligand chemokine) (ELC) (Macrophage inflammatory protein 3 beta) (MIP-3-beta) (Small-inducible cytokine A19)
[Ccl19 Elc Scya19] C-C motif chemokine 19 (Epstein-Barr virus-induced molecule 1 ligand chemokine) (EBI1 ligand chemokine) (ELC) (Small-inducible cytokine A19)
[nrdB Rv0233] R2-like ligand binding oxidase (EC 1.-.-.-) (Ribonucleotide reductase R2 subunit homolog) (Ribonucleotide reductase small subunit homolog)
[XCL1 LTN SCYC1] Lymphotactin (ATAC) (C motif chemokine 1) (Cytokine SCM-1) (Lymphotaxin) (SCM-1-alpha) (Small-inducible cytokine C1) (XC chemokine ligand 1)
[RACK1 GNB2L1 HLC7 PIG21] Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]
[SLIT2] Slit guidance ligand 2
[CD40LG] CD40 ligand (CD40-L) (Tumor necrosis factor ligand superfamily member 5)
[Faslg Apt1Lg1 Cd95l Fasl Tnfsf6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[TNFSF15 TL1 VEGI] Tumor necrosis factor ligand superfamily member 15 (TNF ligand-related molecule 1) (Vascular endothelial cell growth inhibitor) [Cleaved into: Tumor necrosis factor ligand superfamily member 15, membrane form; Tumor necrosis factor ligand superfamily member 15, secreted form]
[TNFSF12 APO3L DR3LG UNQ181/PRO207] Tumor necrosis factor ligand superfamily member 12 (APO3 ligand) (TNF-related weak inducer of apoptosis) (TWEAK) [Cleaved into: Tumor necrosis factor ligand superfamily member 12, membrane form; Tumor necrosis factor ligand superfamily member 12, secreted form]
[TNFSF18 AITRL GITRL TL6 UNQ149/PRO175] Tumor necrosis factor ligand superfamily member 18 (Activation-inducible TNF-related ligand) (AITRL) (Glucocorticoid-induced TNF-related ligand) (hGITRL)
[EFNA3 EFL2 EPLG3 LERK3] Ephrin-A3 (EFL-2) (EHK1 ligand) (EHK1-L) (EPH-related receptor tyrosine kinase ligand 3) (LERK-3)
[FASLG APT1LG1 CD95L FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (Apoptosis antigen ligand) (APTL) (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[Faslg Apt1lg1 Cd95l Fasl gld Tnfsf6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[FASLG CD95L FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[FASLG CD95L FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[FASLG CD95L FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[FASLG CD95L FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[FASLG CD95L FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[FASLG FASL TNFSF6] Tumor necrosis factor ligand superfamily member 6 (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]
[Tnfsf11 Opgl Rankl Trance] Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]
[TNFSF11 OPGL RANKL TRANCE] Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]
[TNFSF14 HVEML LIGHT UNQ391/PRO726] Tumor necrosis factor ligand superfamily member 14 (Herpes virus entry mediator ligand) (HVEM-L) (Herpesvirus entry mediator ligand) (CD antigen CD258) [Cleaved into: Tumor necrosis factor ligand superfamily member 14, membrane form; Tumor necrosis factor ligand superfamily member 14, soluble form]
[CD244 2B4] Natural killer cell receptor 2B4 (NK cell activation-inducing ligand) (NAIL) (NK cell type I receptor protein 2B4) (NKR2B4) (h2B4) (SLAM family member 4) (SLAMF4) (Signaling lymphocytic activation molecule 4) (CD antigen CD244)
[CD40LG CD40L TNFSF5 TRAP] CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form]
[Cd40lg Cd40l Tnfsf5] CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form]
[Cd40lg Cd40l Tnfsf5] CD40 ligand (CD40-L) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form]
[BAIAP2] Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53)
[TNFSF13B BAFF BLYS TALL1 TNFSF20 ZTNF4 UNQ401/PRO738] Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator) (BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1) (TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form]
[Pdcd1lg2 B7dc Btdc Cd273 Pdl2] Programmed cell death 1 ligand 2 (PD-1 ligand 2) (PD-L2) (PDCD1 ligand 2) (Programmed death ligand 2) (Butyrophilin B7-DC) (B7-DC) (CD antigen CD273)

Bibliography :
[31708870] Protease-Activated Receptors in the Intestine: Focus on Inflammation and Cancer.
[31707706] GPCR Allosteric Modulator Discovery.
[31628191] GAIN domain-mediated cleavage is required for activation of G protein-coupled receptor 56 (GPR56) by its natural ligands and a small-molecule agonist.
[31628190] Rare-variant pathogenicity triage and inclusion of synonymous variants improves analysis of disease associations of orphan G protein-coupled receptors.
[31591260] Molecular Pharmacology of Class F Receptor Activation.
[31588246] CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.
[31583945] NanoBiT Complementation to Monitor Agonist-Induced Adenosine A Receptor Internalization.
[31548340] Modulators of CXCR4 and CXCR7/ACKR3 Function.
[31495942] Allosteric modulation of G protein-coupled receptors by amiloride and its derivatives. Perspectives for drug discovery?
[31459371] Structural Modeling and in Silico Screening of Potential Small-Molecule Allosteric Agonists of a Glucagon-like Peptide 1 Receptor.